HeartFocus (V.1.1.1) vs V7 Diagnostic Ultrasound System

HeartFocus (Tool A) is explicitly designed to empower novice users to perform diagnostic-quality heart ultrasounds with real-time AI guidance and a gamified user interface, significantly lowering the barrier to entry for cardiac imaging. In contrast, while the Samsung V7 (Tool B) aims to enhance workflow and user experience for healthcare professionals, it is a full ultrasound system that likely requires a higher level of user expertise.

HeartFocus (Tool A) has demonstrated significant clinical value by enabling 100% of novice-conducted scans to meet diagnostic standards in a pivotal international clinical trial, comparable to expert-acquired scans, directly addressing the shortage of specialists and expanding access to critical cardiac diagnostics. While the V7 Diagnostic Ultrasound System (Tool B) offers a broader suite of advanced AI-powered analytical and measurement tools for various applications, its FDA clearance did not require new clinical studies to support substantial equivalence for its AI features, and its primary value is enhancing existing expert workflows rather than democratizing access for novices.

HeartFocus (Tool A) offers clear pricing transparency with a single license costing $695 for smaller deployments and a 30-day free trial, making it highly accessible and democratizing access to cardiac imaging at a low cost. The V7 Diagnostic Ultrasound System (Tool B), being a full ultrasound system, has a significantly higher price point, with reported prices ranging from $36,252 to $51,953, and less upfront pricing transparency.

The V7 Diagnostic Ultrasound System (Tool B) is a product of Samsung Medison, a large and established medical imaging company, and explicitly supports HIPAA compliance and offers robust DICOM connectivity for seamless integration with PACS, EMRs, and other reporting systems, which are critical for enterprise environments. While HeartFocus (Tool A) also supports DICOM integration and HIPAA-compliant workflows, its parent company, DESKi, is a smaller, newer entity, and its statement that it is not directly subject to HIPAA might require additional scrutiny for some enterprise compliance frameworks.

HeartFocus (Tool A) presents a more disruptive innovation by providing real-time AI guidance for ultrasound probe positioning, enabling novice users to perform diagnostic-quality heart ultrasounds. This fundamentally changes who can perform cardiac imaging and significantly expands access to care. The V7 Diagnostic Ultrasound System (Tool B) offers advanced AI features for automated measurements and workflow efficiency on an existing high-end ultrasound system, which are incremental innovations within established clinical practice.

HeartFocus (Tool A) provides a robust support ecosystem, including a POCUS HeartFocus Certification program, training resources for medical teachers, comprehensive user manuals, FAQs, and tutorial videos. In contrast, while the V7 Diagnostic Ultrasound System (Tool B) is supported by Samsung, specific details about its customer support, structured training programs, or extensive user documentation were less explicitly detailed in the available information.